Equities

Hofseth Biocare ASA

Hofseth Biocare ASA

Actions
Consumer Staples Food Producers
  • Price (NOK)1.43
  • Today's Change0.00 / 0.00%
  • Shares traded17.00
  • 1 Year change-48.93%
  • Beta--
Data delayed at least 15 minutes, as of Nov 05 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Hofseth Biocare ASA is a Norway-based biotech company that offers ingredients and finished products for humans and animals. The Company’s business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.

  • Revenue in NOK (TTM)221.72m
  • Net income in NOK-121.18m
  • Incorporated2009
  • Employees65.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Premium Snacks Nordic AB427.14m10.36m223.82m--22.163.408.700.5240.74450.744531.084.852.607.7812.18--6.30-0.132813.71-0.253741.5239.622.42-0.05750.48894.710.4323--14.6052.12111.69------
Cheffelo AB (publ)1.05bn24.42m330.94m398.0013.690.73314.450.31481.861.8680.6634.781.3554.32121.352,529,572.003.15-5.333.88-6.6943.3538.752.32-3.950.845620.700.2208---7.56-5.50112.49---8.99--
Hofseth Biocare ASA221.72m-121.18m564.97m65.00--4.25--2.55-0.3023-0.30230.55030.33630.55671.739.773,411,062.00-30.43-30.07-55.35-46.4828.6216.61-54.66-104.050.4075-499.360.552--61.7926.2622.35--7.41--
Fodelia Oyj-1.20tn-1.20tn605.14m129.00--4.12----------1.50------------------------0.8151--0.3154--17.64--14,705.78------
Skane mollan AB275.08m16.27m608.03m28.0037.383.8225.932.211.441.4424.4314.141.44--9.309,266,655.008.5110.079.5711.2516.7420.555.917.88----0.0078.90-0.30419.23-28.819.3110.034.94
Apetit Oyj1.93bn106.58m1.02bn298.009.530.8345.690.52811.421.4225.8016.191.383.8228.33477,810.707.581.758.702.5834.3019.915.511.051.27--0.0686125.68-3.41-7.55203.13--2.2813.40
HKFoods Oyj11.55bn-185.61m1.05bn3.01k--0.43452.290.091-0.1744-0.4911.692.161.259.438.91327,291.30-1.62-1.33-2.69-2.016.8128.30-1.30-0.88180.57480.68720.5095---14.99-11.470.00------
Midsona AB3.86bn31.73m1.38bn774.0043.420.44557.350.35680.21280.212825.8920.740.80384.079.934,926,798.000.6611-0.79190.7804-0.930127.5726.250.8225-1.050.702.380.168---2.725.8789.42---13.22--
Atria Oyj20.93bn-131.75m2.59bn3.90k--0.8014.070.1238-0.4053-0.405362.1414.171.7211.3113.68448,485.10-0.67850.3548-0.93980.503910.5410.59-0.39360.21520.5190.86550.40781,342.813.304.03-272.64--19.75-5.59
Data as of Nov 05 2024. Currency figures normalised to Hofseth Biocare ASA's reporting currency: Norwegian Krone NOK

Institutional shareholders

8.28%Per cent of shares held by top holders
HolderShares% Held
Bonafide Wealth Management AG (Liechtenstein)as of 28 Jun 202430.30m7.67%
DNB Asset Management ASas of 30 Aug 20242.38m0.60%
Dimensional Fund Advisors LPas of 30 Sep 202427.30k0.01%
SSgA Funds Management, Inc.as of 03 Oct 20246.09k0.00%
Mediolanum International Funds Ltd.as of 28 Jun 20240.000.00%
More ▼
Data from 28 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.